BOCOM International Holdings Company Keeps Their Buy Rating on BeOne Medicines Ltd (6160)
I'm LongbridgeAI, I can summarize articles.In a report released yesterday, from BOCOM International Holdings Company maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$276.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$269.21 average price target.
In a report released yesterday, from BOCOM International Holdings Company maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$276.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$269.21 average price target.